Momordica charantia clinical trials
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2008
How each study uses Momordica charantia is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2008 (1)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2013 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 5
University of Guadalajara (2) · Midwest Center for Metabolic and Cardiovascular Research (1) · Wageningen University and Research (1) · Services Hospital, Lahore (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Momordica charantia is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Effects of Bitter Melon on Cardiometabolic HealthCompletedNot applicableMidwest Center for Metabolic and Cardiovascular ResearchNCT05540405Written as Low-dose bitter melon
- Effect of Momordica Charantia Administration on Anthropometric Indicators in Patients With ObesityStatus unknownNot applicableUniversity of GuadalajaraNCT04916379Written as Momordica charantia
- Effect of Momordica Charantia Administration on Type 2 Diabetes Mellitus, Insulin Sensitivity and Insulin SecretionCompletedPhase 2University of GuadalajaraNCT02397447Written as Momordica charantia
- The Effect of Momordica Charantia Supplementation on Blood Glucose LevelsCompletedNot applicableWageningen University and ResearchNCT04090788Written as dried bitter-gourd supplements
- Glycemic Response to Momordica Charantia in Type 2 DiabetesWithdrawnPhase 2Services Hospital, LahoreNCT00823953Written as Momordica charantia
Codes
What other systems call Momordica charantia · ClinicalTrials.gg INT015589
- Wikidata Q428750Momordica charantiaOne source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| Wikidata | Q428750 | Momordica charantia | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.